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The purpose of the present study was to analyze the 
metabolism of arachidonic acid (AA) in normal human 
dermis. After incubating homogenized dermis with exog-
enous AA, the extracted lipids were isolated by revers ed-
phase high-performance 'liquid chromatog raphy. Each 
chromatographic peak was characterized by its UV ab-
sorption spectrum and identifi ed by its coelution with the 
appropria te authenti c standard and by radioimmunoassay 
of its eluate fraction. Identified compounds were quanti-
tated by integra ted optical den sity . Homogenized human 
dermis transformed AA into both cyclooxygenase and li-
poxygenase products, but predominantly lS-hydroxy- ei-
cosatetraenoic acid (lS-HETE). Cultured fibroblasts from 
L ipoxygenase enzy mes convert arachidonic acid (AA) into hydro(pero)xy-eicosatetraenoic acids [H(P)ETEs]. T he products of the 5- and the 12-lipoxygenase path-ways have been characterized as mediators of certain types of inflammation [1 ,2], but it is only recently that 
the biologic activities of 15-lipoxygenase products have been elu-
cidated. 15-HETE can inhibit mitogen-induced DNA-synthesis 
in human T lymphocytes [3], and in fractionated human T lym-
phocytes it has been documented that 15-I-IPETE and 15-HETE 
decrease the mitogen response ofT helper cells, but stimulate the 
proliferation of T suppressor cells [4] . In addition to controlling 
cellular immune responses, 15-HETE has the potential to regulate 
5- and 12-lipoxygenase activity in some cell types. In human 
neutrophils 5-lipoxygenase activity is inhibited by 15-HETE [5], 
whereas a murine mast/basophil cell line has its 5-lipoxygenase 
activated by 15-HETE [6]. Furthermore, 15-HETE inhibits the 
12-HETE formation by platelets [7]. 
In the present study we present evidence that 15-HETE is the 
major AA metabolite of human dermis, and that dermis-derived 
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Abbreviations: 
AA: arachidonic acid 
ACN : acetonit ri le 
FBS: feta l bovine serum 
HETE: hydroxy-eicosatetraenoic acid 
MEM: minimal essential medium 
ODS: octadecyl-sil yl silica 
PBS: phosphate-buffered saline 
PG: prostaglandin 
RIA : radioimmunoassay 
RP-HPLC: reversed-phase high-performance liquid 
chromatography 
normal human dermis also m ainly m etabolized AA into 
lS-HETE. To determine whether dermis-derived lS-HETE 
mig ht modify the AA m etabolism of epidermis, normal 
human epidermis was incubated with dermis. Increasing 
amounts of dermis resulted in an increasing inhibition of 
epidermal 12-HETE formation . Similarly, lS-HETE alone 
induced a dose-dependent decrease of epidermal 12-HETE 
formation, while the formation of prostaglandin E 2 was 
unchanged . Since 12-HETE possess the ability to elicit skin 
inflammation and to stimulate epidermal DNA synthesis , 
lS-HETE formation may b e a way whereby dermis reg-
ulates important epidermal activities . ] Inllest D ermatol 
87:494-498, 1986 . 
15-HETE ca n inhibit the 12-HETE formation by human epider-
mis. 
MATERIALS AND METHODS 
Reagents Organic solvents and water of high-performance liq-
uid chromatography (HPLC) grade were from Burdick and Jack-
son Laboratories, Inc, Muskegon, Michigan. Just before use, all 
organic and aqueous solutions were filtered with 0.5 p,-MFH and 
0.22 p,-MGS, respectively (Millipore). AA (Sigma) and [1-14C]AA 
(New England Nuclear) w ere purified by sil icic acid chromatog-
raphy (5-mm glass column pack with 0.25 g Silicar CC-4, Mal-
linckrodt). The column was eluted with diethyl ether:hexane (2:98) 
followed by diethyl ether:hexane (10:90) , the latter containing 
AA . 
Prostaglandins D2 , E2 , and F2 (PGD2 , PGE2, and PGF2a) were 
from Sigma. 12-HETE was a gift from Dr. Sven Hammarstrom, 
Department of Physiological Chemistry, Karolinska Institutet, 
Stockholm, Sweden. 15(S)-HETE was form ed by oxygenation 
of AA by soybean lipoxygenase as described by Vanderhoek et 
al [5] followed by reduction with triphosphine . The ex tract con-
taining 15-HETE was subj ected to reversed-phase (RP)-HPLC 
for purification (see below) . Quantification of15(S)-HETE formed 
by soybean Iipoxygenase was done by integrated optical density 
using an integ rator that was programmed using injections of au-
thentic 15(S)- HETE (Cayman Chemical Co, Ann Arbor, Mich-
iga n). Minimal essential medium (MEM), fetal bovine serum 
(FBS), penicillin , and streptomycin were from Flow Laboratories, 
Inc., Rockville, Maryland. Collagenase (type II-S) and trypsin 
(bovine pancreas type 1II) were purchased from Sigma Chemical 
Co, St. Louis, Missouri. Corning plastic products were used in 
all experiments. All other reagents were reagent grade. 
Dennis Informed consent was obtained from healthy adult vol-
unteers without a history of skin disease. Subjects taking non-
steroidal anti-inflammatory drugs within the last 4 weeks were 
excluded. 
After intracutaneous injection of 1 % lidocaine, strips of skin 
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(epidermis and superficial dermis) were obtained from the but-
tocks with a keratome set at 0.2mm. T he biopsy was immedi atel y 
placed o n ice and transported to the laboratories. After being 
immersed in Dulbecco's phosphate-buffered sa line (PBS) at 55°C 
for 25 s the epidermis was peeled off the dermis, which was 
immediately placed in liquid nitrogen. The level of cleavage was 
confirmed in histologic frozen sections stained with hematoxylin 
and eosin . D ermis was powdered with a mortar and pestle pre-
cooled with liquid nitrogen. After determination of the wet weight, 
the tissue (100-200 m g) was suspended in 6 vol of ice-cold PBS 
(pH 7.4) with 2 mM glucose and 5 mM reduced glutathione. The 
tissue was then sonicated at O°C. 
Homogenized dermis was incubated with 25 /LM AA (Sigma) 
and 0.2 /LC i/ ml [J-I 4C]AA (55.0 mC i/ mmol , N ew England Nu-
clear) for 30 min at 37°C. An incubation time of 30 min was 
chosen because preliminary experiments showed that a plateau 
was reached at that time. Incubation was stopped by adding 4 
vol of ice-cold methanol containing 3H-Iabeled eicosanoids (10,000 
cpm/sample) as intern al standards. The sample was left at 4°C 
and then centrifuged at 600 g for 10 min to pellet denatured 
proteins. The supernatant was collected and diluted to 15% meth-
anol with 1.0 N formi c acid (pH 3). Octadecyl-silyl silica (ODS) 
columns (Waters Associates) were used for lipid extraction as 
described by Luderer et al [8]. The lipid fraction was then taken 
to dryness under a stream of N 2 and resuspended in 25 /LI meth-
anol. This m ethanol fraction was subjected to RP-HPLC using a 
Hewlett Packard HP 1090 equipped with a diode array detector 
on a H ypersil ODS column (100 X 2. 1 mm, 5 /Lm particles) 
elu ted w ith acetonitrile (AC N) in aqueous H3P04 (pH 3). T he 
mobile phase was 20% ACN with linear increase to 30% over 2 
min, followed by linear increases to 33% from 2-10 min , to 53% 
fro m 10-1 8 min , to 57% from 18-23 min , and to 85% from 
23-28 min . Fro m 28-33 min ACN was kept at 85%. This RP-
HPLC procedure was modified from VanRollins et al [9]. The 
solvent flow was 0.8 ml/min at 25°C. The eluent was split be-
tween a fraction collector and a radioactivity monitor equipped 
with a glass scintillator cell (Radiomatic, Flo-one model HS) . The 
3H and 14C dpm were recorded sepa rately, and the areas of the 
radioactive peaks were also integrated. Data were analyzed using 
an integrator th at was prog rammed using injections of authentic 
standards to allow quantitation of the peaks. The elution times 
of authentic samples were standardized dail y. U sing coinjections 
of 3H-Iabeled authentic standards it was ascertained that their 
elution times were identical in dermal samples and in pure solvent. 
The pellet of proteins by methanol w as washed by centrifu-
gation in 3% perchloracetic acid, and the protein content was 
determined by the fluorescamine method described by Uden-
friend et al [10]. 
Radioimmunoassay (RIA) For PGE2 an assay usin g a rabbit 
anti-PGE2 antibody and [3H]PGE2 (100-200 Cilm mol) was per-
for m ed as described by Fitzpatrick and Bundy [11] . Dextran-
coa ted charcoa l was used to separate bound from free ligand . 
Fo[ 15-HETE and 12-HETE a dextran-coated charcoal sepa-
ra tion RIA was used according to the instructions of the manu-
fac ture[oftheantibodies (Seragen, Boston, Massachusetts). [3H]15-
HETE (30-60 Ci/mmol) and [3H)1 2-HETE (40-80 C i/ mmol) 
were from N ew England Nuclea[ (Boston , Massachusetts). Sam-
ples were diluted in 0.1 M phosphate buffer containing 0.9% N aCl 
and 0.1 % bovine serum albumin . The pH of the buffer was 7.2 
for 15-HETE and 8.5 for 12-HETE. Each sample was assayed at 
3 dilutions. In the 15-HETE assay a cross-reactivity of 7% with 
12-HETE was found. In the 12-HETE assay the cross-reactivity 
with 15-HETE was 6%. In both assays the cross-reactivity with 
5-HETE was less than 0.1 %. 
Fibroblast Cultures Cultures of human dermal fibroblas ts were 
established as ea rlier described by us [1 2]. Skin biopsies w ere 
incubated with trypsin 0.25% in PBS containing 5 mM glucose 
(pH 7.0) for 30 min at 37°C. After separating epidermis from 
dermis, fibrobl as ts were obtained by incubating the dermal part 
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with 0. 1 % collagenase in PBS (pH 7.4) for 30 min at 37°C. After 
aspirating the collagenase, MEM w ith 10% FBS, 50 IU/ ml pen-
icill in, and 50 /Lg/ml streptomycin was added and the dermis was 
scraped . Ten milliliters of suspended fibroblasts (0.5 X 106/ ml) 
were added to each 25-cm2 tissue culture flask . M edium was 
changed twice every week. When cultures became confluent, they 
were incubated in 3 ml PBS w ith 5 mM g lucose (pH 7.4) and 1.0 
/LM calcium ionophore A23187 and 0.01 /LM [1 4C]AA at 37°C for 
60 min. Then the flasks were put on ice and the supernatant 
collected together with the cells (scraped off in 12 111.1 ice-cold 
methanol) . Lipids were extracted and analyzed as described for 
homogenized dermis. 
Statistical Analysis Results were expressed as mean ± SD . 
Statistica l significance was assessed by Wilcoxon 's test for paired 
and unpaired sa mples. 
RESULTS 
A RP-HPLC chromatogra m of lipids extracted from hom oge-
nized human dermis is shown in Fig 1. Recorded as UV absor-
bance RP-HPLC produced 2 peaks. The m ajor peak (I) chro-
matographed with authentic 15-HETE and the minor peak (II) 
with authentic 12-HETE. Both peak I and peak II exhibited a 
maximum UV absorbtion at 238 mm (Fig 1) and were radioactive 
(Fig 2). Because the sepa ration of 15-HETE and 12-HETE by 
radioactivity RP-HPLC was incomplete (Fig 2), the subsequent 
quantitation of HETEs was based upon integrated UV absor-
bance. The eluate fractions of peaks I and II were collected and 
anal yzed by RIA for 15-HETE and 12-HETE, respectively (Table 
I) . For both 15-HETE and 12-HETE, the amount measured as 
immunoreactivity was at the sa me level as that measured by UV 
absorbance (Table I) . The identity of the third peak observed at 
20 min is unknown (Fig 1). It was not radioactive (Fig 2) and 
therefo re not a metabolite of AA. 
Because the UV detector was set at 270 nm or 235 nm in Fig 
1, PGs exhibiting maximum UV absorbance at 190 mm were not 
detected . However, when the RP-HPLC chromatogram was re-
corded as 14C radioactivity, a small peak coeluting w ith PGE2 
was identi fied (Fig 2). 
In contras t to dermis, human epidermis is characterized by a 
very active 12-lipoxygenase pathway [1 3). To determine w hether 
dermis (i.e., 15-HETE) can m odify the 12-lipoxygenase activity 
of epidermis, 12-HETE formation was measured in epidermis 
and dermis, whether incubated together or separately (Table II). 
The tota l 15-HETE formation in epidermis plus dermis was in-
dependent of the incubation procedure. In contras t , the total 12-
HETE formation was greater w hen epidermis and dermis were 
incubated separa tely . 
To provide further ev idence that dermis can modify epide[mal 
12-lipoxygenase activity, epidermis was incubated with increas-
ing amounts of dermis (Fig 3). Unlike boiled dermis, normal 
dermis inhibited the formation of 12-HETE in a dose-dependent 
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Figure 1. RP-HPLC chromatogram oflipids extracted from human der-
mis incubated with 25 /LM AA for 30 min at 37°C. A,TOIVS indicate elu-
tion times of authentic standards. [ll set is the UV absorbtion of peaks [ 
and II. 
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Figure 2. Radioactivity RP-HPLC chromatogram of lipids extracted from 
human dermis incubated with 0.2 JLCi/m l AA (55 mCI/mmol) for 30 mll1 
at 37"C. Arrol/ls indicate elution timcs of authcntic standards. 
way. To assess whether 15-HETE might be responsible for the 
inhibitory effect of derl1lis on epidermal 12-HETE formatIOn, 15-
HETE synthesized by soy bean lipoxygenase was added to epi-
dermis (Fig 4). 15-HETE produced a dramatic decrease of 12-
HETE formation, and at a 15-HETE concentration of 10- 4 M 
12-HETE formation was almost completely abolished. 15-HETE 
did not alter epidermal PGE2 formation (Fig 4). 
To determine whether fibroblasts mi ght be the source of dermal 
15-HETE, primary cultures of human dermal fibroblasts were 
in cubated with AA for 60 min at 37°C in the presence of 1 f.l.M 
calcium ionophore A23187. RP-HPLC ana lysis ofl ipids extracted 
from the culture supernatants demonstrated peaks coeluting with 
authentic standards of PGF2a , PGE2 , 15-HETE, and 12-HETE, 
respectively (Fig 5). 15-HETE was the predominal1t arachid onate 
metabolite in each of 5 fibroblast cultures from 5 normal vol-
unteers (data not shown) . 
D ISCUSSION 
In this study we have demonstrated that 15-HETE is the main 
metaboli te of AA in homogenized human dermis. Furthermore, 
both dermis and lS-HETE alone could specifically inhibit the 
formation of epidermal 12-HETE. 
The common ability of 15-HETE and dermis to decrease the 
12-HETE formation of epidermis does not prove that 15-HETE 
in fact is responsible for the inhibitory effects of dermis on epi-
dermal 12-lipoxygenase activity. N evertheless, it can be calcu-
lated that the 30 nmol 15-HETE formed in 30 min by dermis 
resu lts in a 15-HETE concentration of -2 X 10- 6 M. Using Fig 
5 it can be extrapolated that this 15-HETE concentration results 
in a 25% inhibition of epidermal 12-HETE formation. It can 
therefore be concluded that dermis is ab le to produce 15-HETE 
in amounts ca pable of inhibiting epidermal 12-HETE formation. 
Since 15-HETE does not affect PG formation in epidermis, the 
selective inhibition of 12-HETE formation does not appear to be 
due to a shift of products from the lipoxygenase to the cycloox-
ygenase pathway. Although small amounts of an epidermal di-
Table I. Formation of 15-HETE (Peak I) and 12-HETE 
(Peak II) by Hun1.an Dermis Incubated with 25 JLM Arachidonic 
Acid for 30 Min 
Peak 
UV Absorbance" 
(nmol/g protein/3D min) 
Immunoreacti vitl 
(nmol/g protcin/3D min) 
II 
3D ± 5 
9 ± 2 
Results arc expressed as means ± SO (n = 7). 
' Integrated o pti cal density at 23S nm durin g RP- HPLC. 
27 ± 7 
7 ± 3 
hEluate fra ctions of se parated compounds by RP-HI'LC were analyzed by RIA . 
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Table II. Formation of 15-HETE and 12-HETE by 
Homogenized Human Skin (Epidermis Plus Dermis) 
Incubation 
or Epidermis 
and Dermis 
Together" 
Scparatell 
15-HETE 
(nmol/g protein/3D min) 
22 ± 4 
24 ± 5 
12-HETE 
(nmol/g protein/3D min) 
33 ± 7 
43 ± 7' 
Results were ex pressed as mean ± SO (11 = 7). 
"Epidermis and dermis separated by exposure to SsoC for 2S s and then incubated 
together. 
'Epidermis and dermis separated by exposure to SsoC for 2S s and then incubated 
separa tel y. The total formation o f IS-HETE and ·12-HETE. respectively. was ca l-
culated by adding the va lues from the 2 compartments. 
'1' < 0.00 1 (separately vs together). 
HETE were produced in the presence of 15-HETE (data not 
shown), the decrease in 12-HETE ca nnot be explained by a Con-
version of 12-HETE or one of its precursors into this di-HETE. 
T herefore, the effects of 15-HETE on 12-HETE generation ap-
pear to be ca used by an inhibition of the 12-lipoxygenase enzyme. 
T he inhibition of epidermal 12-lipoxygenase by 15-HETE may 
be of physiologic relevance, because epidermis with dermis at-
tached produces less 12-HETE than w hen analyzed alone. The 
regulatory action of 15-HETE on epidermal 12-lipoxygenase is , 
however, more pronounced at doses unlikely to be obtained in 
vivo. T his observation implies that a stimulation of the 15-li-
poxygenase activity or the topical application of pharmacologic 
doses of 15-HETE may be utilized in the regulation of epidermal 
12-lipoxygenase activity. In this context it is of interest that the 
content of 12-HETE is dramatically elevated in psoriatic skin 
lesions (14). Since 12-HETE can induce neutrophil migration 
[1 5, 16] and epidermal keratinocyte proliferation [17,1 8], both typical 
features of psoriatic skin lesions, it would be of interest to examine 
whether a hi gh concentration of topically applied 15-HETE 
produces an improvement of psoriasis. 
Considering the potential use of 15-HETE, it has to be stressed 
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th a t lS-HETE possesses bio logic acti v ities o th er than inhibiting 
12-lipoxygen ase ac tivity . The effect of lS-HE T E o n S-Iipoxy-
genase activity is dependent on the cell ty pe s tudied. The S-lipo x-
ygen :1se of human neutrophils is inhibited by 15-HETE [5], whereas 
th e dormant 5-lipoxygenase of a murin e m as t/ basophil cell lin e 
is activated by 15-HETE [6] . Furthermo re, 15- H ETE m ay control 
cellular immune respo nses by decreasin g the mitogen res po nse 
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Figure 5. Radioactivity RP-HPLC chromatogram of lipids extracted from 
cultured human fibroblasts incubated with 1 fJ-M Ca-ionophore A23187 
and 0. 01 fJ-M 114C ]-AA for 60 min at 37°C. A rrows indicate elution times 
of authentic standards. 
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of T helper cells and at the sa m e tim e in creasin g th e p ro li fera tio n 
ofT suppressor cells [4]. 
T he cellular source of dermal 15-H ETE rem ains to be estab-
lished , alth o ug h we and o ther in ves ti ga to rs [19] have fo und that 
l S-HETE is the pred o min ant li poxygenase p roduct of cultured 
skin fibro blas ts. O ther po tential sources of l S-HETE are mast 
cells, end o thelial cel ls, and append ageal structures. R at serosa l 
mast cells have been sho wn to produce l S-HETE [20] bu t PGD~ 
and 5-lipoxygenrise pro du cts ri re p" edomin ant am o ng m as t cell 
eicosano ids [21]. To our knowled ge, endo thelial cells have no t 
been sho wn to release 15-lipo x ygenase produ cts, and it is unli kely 
that appendagea l stru ctures con tribute to a sig nifi cant d egree to 
the results, beca use we an alyzed o nl y the superfi cial part of der-
mIs. 
In summary , th e o bserva tio ns m ad e in the present study su ggest 
that a dermal l S-HETE has the ability to regulate the syn thesis 
of epiderm al 12-H E T E w ith pro inAammato ry and mi togenic 
properties. In this context it is of in te res t that unidentified d erm al 
stru ctures have been sho wn to affect the p rolife rati ve rate of hu-
m an epiderm al ke ratinocytes 1' 22,23] . It is, there fo re , beco ming 
apparent th at dermis and its produ cts m ay pl ay an importan t 
regulato ry ro le in the expressio n of epiderm al fun ctio n . Pe rh aps 
this regul ato ry fun ctio n is partiall y m ediated by p assage of A A 
m etabo lites from dermis to epidermi s. 
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